Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.
ANTI-MYCOBACTERIUM AVIUM COMPLEX ANTIBODIES NOT SUFFICIENT TO DIAGNOSE NTM PULMONARY DISEASE
Researchers in Japan have assessed the efficacy of using a combination of anti-Mycobacterium avium complex (MAC) antibody testing and clinical findings to identify nontuberculous mycobacterial pulmonary disease (NTM-PD).
They found that anti-MAC antibodies can be positive in patients not harboring MAC. Sputum samples or bronchoscopic examination are needed to confirm diagnosis.













